AIM ImmunoTech Posts Virtual Investor Key Opinion Leader Segment Spotlighting Ampligen Breakthrough Data in Pancreatic Cancer
Go back to AIM ImmunoTech Posts Virtual Investor Key Opinion Leader Segment Spotlighting Ampligen Breakthrough Data in Pancreatic Cancer| Aerosonic Corp. (NYSE: AIM) | Delayed: 0.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.38 | 52 Week High | $8.92 | |||
| Open | $0.38 | 52 Week Low | $2.64 | |||
| Day High | $0.39 | P/E | 0.61 | |||
| Day Low | $0.36 | EPS | $0.62 | |||
| Volume | 1,383,100 | |||||

